421 related articles for article (PubMed ID: 9813525)
1. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat.
Buerkle H; Yaksh TL
Br J Anaesth; 1998 Aug; 81(2):208-15. PubMed ID: 9813525
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of two intraventricularly injected alpha 2 agonists, ST-91 and dexmedetomidine, on electroencephalogram, feeding, and electromyogram.
Dowlatshahi P; Yaksh TL
Anesth Analg; 1997 Jan; 84(1):133-8. PubMed ID: 8989014
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine injection into the locus ceruleus produces antinociception.
Guo TZ; Jiang JY; Buttermann AE; Maze M
Anesthesiology; 1996 Apr; 84(4):873-81. PubMed ID: 8638842
[TBL] [Abstract][Full Text] [Related]
4. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
Hayashi Y; Guo TZ; Maze M
Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
[TBL] [Abstract][Full Text] [Related]
5. A role for spinal, but not supraspinal, alpha(2) adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic.
Svokos K; Nalwalk JW; Leurs R; Menge WM; Timmerman H; Hough LB
Brain Res; 2001 Dec; 923(1-2):12-9. PubMed ID: 11743967
[TBL] [Abstract][Full Text] [Related]
6. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Aley KO; Levine JD
J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
[TBL] [Abstract][Full Text] [Related]
7. Peripheral nociceptive effects of alpha 2-adrenergic receptor agonists in the rat.
Khasar SG; Green PG; Chou B; Levine JD
Neuroscience; 1995 May; 66(2):427-32. PubMed ID: 7477883
[TBL] [Abstract][Full Text] [Related]
8. alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception.
Sierralta F; Naquira D; Pinardi G; Miranda HF
Br J Pharmacol; 1996 Oct; 119(3):551-4. PubMed ID: 8894177
[TBL] [Abstract][Full Text] [Related]
9. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA
Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216
[TBL] [Abstract][Full Text] [Related]
10. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.
Gil DW; Cheevers CV; Kedzie KM; Manlapaz CA; Rao S; Tang E; Donello JE
Anesthesiology; 2009 Feb; 110(2):401-7. PubMed ID: 19194166
[TBL] [Abstract][Full Text] [Related]
12. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
13. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat.
Hayashi Y; Rabin BC; Guo TZ; Maze M
Anesthesiology; 1995 Oct; 83(4):816-22. PubMed ID: 7574062
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.
Takano Y; Yaksh TL
J Pharmacol Exp Ther; 1992 May; 261(2):764-72. PubMed ID: 1349648
[TBL] [Abstract][Full Text] [Related]
15. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
Seidel WF; Maze M; Dement WC; Edgar DM
J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and hemodynamic effects of a novel alpha2-adrenergic agonist, MPV-2426, in sheep.
Eisenach JC; Lavand'homme P; Tong C; Cheng JK; Pan HL; Virtanen R; Nikkanen H; James R
Anesthesiology; 1999 Nov; 91(5):1425-36. PubMed ID: 10551595
[TBL] [Abstract][Full Text] [Related]
17. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
Takano Y; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):438-46. PubMed ID: 1678011
[TBL] [Abstract][Full Text] [Related]
18. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
19. Different roles of alpha 2-adrenoceptors of the medulla versus the spinal cord in modulation of mustard oil-induced central hyperalgesia in rats.
Mansikka H; Idänpään-Heikkilä JJ; Pertovaara A
Eur J Pharmacol; 1996 Feb; 297(1-2):19-26. PubMed ID: 8851161
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
